Previous studies have found increased serum levels of BAFF in a subset of patients with idiopathic inflammatory myopathies or MCTD [16, 17] compared to healthy individuals, and that patients with ILDs had higher BAFF levels than patients without ILDs. This evidence concerns the gene TNFSF13B and idiopathic inflammatory myopathy.